Evidence map›Paper›PMID 30118702›Full record

ArticleExperimental and molecular pathology2018

HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages.

Alexander N Orekhov, Tatiana Pushkarsky, Yumiko Oishi, Nikita G Nikiforov, Andrey V Zhelankin, Larisa Dubrovsky, Vsevolod J Makeev, Kathy Foxx, Xueting Jin, Howard S Kruth and 6 more

Open access · greenAbstract read
In one paragraph

Article in Experimental and molecular pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. New Strategies to Promote Macrophage Cholesterol Efflux.Frontiers in cardiovascular medicine · 2021
    Article
  5. Article
  6. Trained Circulating Monocytes in Atherosclerosis:Frontiers in pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 4 countries.

Alexander N OrekhovInstitute of General Pathology and Pathophysiology, Moscow, Russia; Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.
Tatiana PushkarskyThe George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Yumiko OishiDepartment of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Nikita G NikiforovInstitute of General Pathology and Pathophysiology, Moscow, Russia; Laboratory of Medical Genetics, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Moscow, Russia; Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Andrey V ZhelankinLaboratory of postgenomic research, Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.
Larisa DubrovskyThe George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Vsevolod J MakeevVavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia; Scientific Center "Kurchatov Institute", Research Institute for Genetics and Selection of Industrial Microorganisms, Moscow, Russia; Moscow Institute of Physics and Technology (State University), Dolgoprudny, Moscow, Region, Russia; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Kathy FoxxKalen Biomedical LLC, Montgomery Village, MD, USA.
Xueting JinExperimental Atherosclerosis Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Howard S KruthExperimental Atherosclerosis Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Igor A SobeninInstitute of General Pathology and Pathophysiology, Moscow, Russia; Laboratory of Medical Genetics, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Moscow, Russia.
Vasily N SukhorukovInstitute of General Pathology and Pathophysiology, Moscow, Russia; Sorbonne Université, Inserm, Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, Hôpital de la Pitié, Paris, France.
Emile R ZakievInstitute of General Pathology and Pathophysiology, Moscow, Russia; Sorbonne Université, Inserm, Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, Hôpital de la Pitié, Paris, France.
Anatol KontushSorbonne Université, Inserm, Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, Hôpital de la Pitié, Paris, France.
Wilfried Le GoffSorbonne Université, Inserm, Institute of Cardiometabolism and Nutrition (ICAN), UMR_S1166, Hôpital de la Pitié, Paris, France.
Michael BukrinskyThe George Washington University School of Medicine and Health Sciences, Washington, DC, USA. Electronic address: mbukrins@gwu.edu.
Inserm · FRGeorge Washington University · USInstitute of Experimental Cardiology · RUNational Institutes of Health · USEngelhardt Institute of Molecular Biology · RUFederal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUTokyo Medical and Dental University · JP

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Mechanism Of Cholesterol Accumulation In Human AtherosclerosisZIAHL002832 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KRUTH, HOWARD S · 2009 to 2019
$12.3M
HIV Disease and Impairement of High Density Lipoprotein MetabolismR01HL101274 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, FITZGERALD, MICHAEL LEO · 2010 to 2015
$4.0M
Metabolic complications of HIV disease caused by Nef released from HIV-infected cellsR01HL131473 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, SVIRIDOV, DMITRI · 2016 to 2019
$1.6M
NHLBI NIH HHS R01 HL101274NHLBI NIH HHS R01 HL131473NIAID NIH HHS P30 AI117970
6 · The paper itself

Abstract

High density lipoproteins (HDL) are key components of reverse cholesterol transport pathway. HDL removes excessive cholesterol from peripheral cells, including macrophages, providing protection from cholesterol accumulation and conversion into foam cells, which is a key event in pathogenesis of atherosclerosis. The mechanism of cellular cholesterol efflux stimulation by HDL involves interaction with the ABCA1 lipid transporter and ensuing transfer of cholesterol to HDL particles. In this study, we looked for additional proteins contributing to HDL-dependent cholesterol efflux. Using RNAseq, we analyzed mRNAs induced by HDL in human monocyte-derived macrophages and identified three genes, fatty acid desaturase 1 (FADS1), insulin induced gene 1 (INSIG1), and the low-density lipoprotein receptor (LDLR), expression of which was significantly upregulated by HDL. We individually knocked down these genes in THP-1 cells using gene silencing by siRNA, and measured cellular cholesterol efflux to HDL. Knock down of FADS1 did not significantly change cholesterol efflux (p = 0.70), but knockdown of INSIG1 and LDLR resulted in highly significant reduction of the efflux to HDL (67% and 75% of control, respectively, p < 0.001). Importantly, the suppression of cholesterol efflux was independent of known effects of these genes on cellular cholesterol content, as cells were loaded with cholesterol using acetylated LDL. These results indicate that HDL particles stimulate expression of genes that enhance cellular cholesterol transfer to HDL.

Indexed as

AtherosclerosisATP Binding Cassette Transporter 1Biological TransportCholesterolCholesterol, HDLDelta-5 Fatty Acid DesaturaseFatty Acid DesaturasesFoam CellsGene Expression ProfilingGene Expression RegulationGene SilencingHumansIntracellular Signaling Peptides and ProteinsLipoproteins, HDLMacrophagesMembrane ProteinsATP Binding Cassette Transporter 1CholesterolCholesterol, HDLDelta-5 Fatty Acid DesaturaseFADS1 protein, humanFatty Acid DesaturasesINSIG1 protein, humanIntracellular Signaling Peptides and ProteinsLDLR protein, humanLipoproteins, HDLMembrane ProteinsReceptors, LDLRNA, MessengerRNA, Small InterferingAtherosclerosisCholesterol effluxHDLLipid metabolismMonocyte-derived macrophagesTranscriptome analysis

Identifiers

PMID30118702
PMCPMC6247801
OpenAlexW2886911620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.